dc.contributor.author | Yildirim, Alper | |
dc.contributor.author | Atmaca, Ufuk | |
dc.contributor.author | Keskin, Ali | |
dc.contributor.author | Topal, Meryem | |
dc.contributor.author | Celik, Murat | |
dc.contributor.author | Gulcin, Ilhami | |
dc.contributor.author | Supuran, Claudiu T. | |
dc.date.accessioned | 2021-11-09T19:49:35Z | |
dc.date.available | 2021-11-09T19:49:35Z | |
dc.date.issued | 2015 | |
dc.identifier.issn | 0968-0896 | |
dc.identifier.issn | 1464-3391 | |
dc.identifier.uri | https://doi.org/10.1016/j.bmc.2014.12.054 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12440/4077 | |
dc.description.abstract | Sulfonamides represent a significant class of biologically active compounds that inhibit carbonic anhydrase (CA, EC.: 4.2.1.1) isoenzymes involved in different pathological and physiological events. Sulfonamide CA inhibitors are used therapeutically as diuretic, antiglaucoma, antiobesity and anticancer agents. A series of new sulfonamides were synthesized using imides and tosyl chloride as starting materials. These N-acylsulfonamides efficiently inhibited the cytosolic human carbonic anhydrase isoenzymes I, and II (hCA I, and II), with nanomolar range inhibition constants ranging between 36.4 +/- 6.0-254.6 +/- 18.0 and 58.3 +/- 0.6-273.3 +/- 2.5 nM, respectively. (C) 2015 Elsevier Ltd. All rights reserved. | en_US |
dc.description.sponsorship | Ataturk UniversityAtaturk University [TUBITAK 110T483]; Research Chairs Program at King Saud University | en_US |
dc.description.sponsorship | This study was financed by Ataturk University (TUBITAK 110T483). Additionally, Ilhami Gulcin would like to extend his sincere appreciation to the Research Chairs Program at King Saud University for funding this research. | en_US |
dc.language.iso | eng | en_US |
dc.publisher | Pergamon-Elsevier Science Ltd | en_US |
dc.relation.ispartof | Bioorganic & Medicinal Chemistry | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | Sulfonamide | en_US |
dc.subject | Imide | en_US |
dc.subject | N-Acylsulfonamide | en_US |
dc.subject | Carbonic anhydrase | en_US |
dc.subject | Enzyme purification | en_US |
dc.subject | Enzyme inhibition | en_US |
dc.title | N-Acylsulfonamides strongly inhibit human carbonic anhydrase isoenzymes I and II | en_US |
dc.type | article | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.description.wospublicationid | WOS:000353380400029 | en_US |
dc.description.scopuspublicationid | 2-s2.0-84937765332 | en_US |
dc.department | Gümüşhane Üniversitesi | en_US |
dc.authorid | GULCIN, Ilhami / 0000-0001-5993-1668 | |
dc.authorid | ATMACA, Ufuk / 0000-0002-5598-0443 | |
dc.authorid | Supuran, Claudiu / 0000-0003-4262-0323 | |
dc.identifier.volume | 23 | en_US |
dc.identifier.issue | 10 | en_US |
dc.identifier.startpage | 2598 | en_US |
dc.identifier.doi | 10.1016/j.bmc.2014.12.054 | |
dc.identifier.endpage | 2605 | en_US |
dc.authorwosid | Keskin, Ali / AAZ-8763-2020 | |
dc.authorwosid | yildirim, Alper / ABI-3876-2020 | |
dc.authorwosid | keskin, ali / ABC-8286-2020 | |
dc.authorwosid | GULCIN, Ilhami / F-1428-2014 | |
dc.authorwosid | ATMACA, Ufuk / AAU-8138-2020 | |
dc.authorwosid | Atmaca, Ufuk / AAB-2504-2019 | |
dc.authorscopusid | 56489873600 | |
dc.authorscopusid | 35145213300 | |
dc.authorscopusid | 56157763100 | |
dc.authorscopusid | 55929192400 | |
dc.authorscopusid | 7101855316 | |
dc.authorscopusid | 35509141500 | |
dc.authorscopusid | 7102904152 | |
dc.description.pubmedpublicationid | PubMed: 25863492 | en_US |